All products are for Professional Use Only (PUO) — not intended for human or animal consumption
Published research summaries for peptides, small molecules, and amino acid blends. All compounds carry a Research Use Only (RUO) designation and are intended for laboratory research purposes.
Showing 11 compounds in "Growth Hormone & Performance"
A synthetic growth hormone-releasing hormone (GHRH) analog conjugated with a Drug Affinity Complex (DAC) that extends its half-life to approximately 6-8 days. Studies have investigated its ability to sustain elevated growth hormone and IGF-1 levels.
A short-acting GHRH analog (Modified GRF 1-29) without the Drug Affinity Complex, producing brief, pulsatile growth hormone release that more closely mimics natural GH secretion patterns.
A synthetic hexapeptide growth hormone secretagogue that acts as a ghrelin receptor (GHS-R1a) agonist. Studies have investigated its potent stimulation of growth hormone release from the anterior pituitary.
A synthetic hexapeptide growth hormone secretagogue with strong GH-releasing activity and notable appetite-stimulating properties. Studies have investigated its role in growth hormone release and gastric motility.
The C-terminal fragment of human growth hormone (amino acids 176-191) studied for its lipolytic properties. Research has investigated its ability to modulate fat metabolism without the growth-promoting or diabetogenic effects of full-length hGH.
A potent synthetic hexapeptide growth hormone secretagogue. Studies have investigated its strong GH-releasing activity and additional cardioprotective properties mediated through CD36 receptor binding.
A long-acting analog of insulin-like growth factor 1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. Studies have investigated its enhanced anabolic activity and reduced IGF binding protein affinity.
A selective pentapeptide growth hormone secretagogue that stimulates GH release without significant effects on cortisol, prolactin, or appetite. Studies have investigated its clean GH-releasing profile.
A synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH 1-29). An extensively studied compound that has been used in diagnostic evaluation of growth hormone secretory capacity.
A stabilized GHRH analog with a trans-3-hexenoic acid modification. An extensively studied compound that has been investigated for its effects on GHRH receptor-mediated signaling and visceral adipose tissue metabolism.
A splice variant of insulin-like growth factor 1 (IGF-1Ec in humans, IGF-1Eb in rodents) produced in response to mechanical loading of muscle tissue. Studies have investigated its role in satellite cell activation and muscle repair mechanisms.
Research Use Only (RUO): The information presented in this library summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. All compounds referenced carry a Research Use Only designation and are intended for laboratory research use only. They are not intended for human or animal consumption. Consult qualified professionals before making any health-related decisions.